The in vitro part demonstrated that both glucagon and Retatrutide instantly diminished ANGPTL3/8 secretion from hepatocytes, which result was blocked by a glucagon receptor (GCGR) antagonist. These findings advise the GCGR agonism of Retatrutide contributes to the reduction in circulating ANGPTL3/ei